Phase ll study of Panitumumab for advanced colorectal cancer which has prior therapy of Bevacizumab
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2620619
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: FOLFOX+Panitumumab repeat every 14 days until discontinuance criteria.
FOLFIRI+Panitumumab repeat every 14 days until discontinuance criteria.
Primary outcome(s): Response Rate:RR
Study Design: Parallel Non-randomized
创建时间：
2011-02-15
